LEN for PrEP: Lessons from Three Early Adopter Countries

November 19, 2026

Since December 2025, lenacapavir (LEN) for PrEP has been introduced in 10 African countries, hitting introduction milestones with record speed. AVAC, with support from the US Bureau of Global Health Security and Diplomacy (GHSD), partnered with Lvcthealth in Kenya, Pakachere Institute of Health and Development Communication in Malawi, and HEPS-Uganda, along with Ministries of Health (MoH) and the US Embassies in the three countries, to advance community-led demand generation, capacity-building and evidence-informed implementation to speed product introduction.

AVAC is pleased to share our latest impact report, Advancing Access to LEN for PrEP, highlighting the approaches that led to strong community-centered LEN introductions in Kenya, Malawi and Uganda. It documents lessons learned and shares resources to help other countries determine how to effectively prepare for and deliver LEN and future PrEP options. 

In a recent webinar, AVAC was joined by representatives from Ministries of Health and implementing partners who shared rollout experiences and how strategies can be adapted to support choice-centered LEN introduction in other countries. 

“Demand generation is a systems investment, not a campaign. Every time people hear demand generation, the question is what’s the campaign? But we know that this goes way, way beyond just a campaign.”

Patriciah Jeckonia
Lvcthealth

Photo credit: Frontline AIDS

Explore the Executive Summary for a quick overview of achievements and insights and access the full report here. On our country pages, dive into the specific details of how these projects supported LEN rollout in Kenya, Malawi, and Uganda. 

Additional LEN Resources